eXoZymes, Inc. (EXOZ)
NASDAQ: EXOZ · Real-Time Price · USD
7.47
+0.09 (1.24%)
Mar 20, 2026, 12:27 PM EDT - Market open
eXoZymes Employees
eXoZymes had 31 employees as of December 31, 2024. The number of employees increased by 2 or 6.90% compared to the previous year.
Employees
31
Change (1Y)
2
Growth (1Y)
6.90%
Revenue / Employee
n/a
Profits / Employee
-$269,022
Market Cap
62.67M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 31 | 2 | 6.90% |
| Dec 31, 2023 | 29 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| TScan Therapeutics | 142 |
| MindWalk Holdings | 102 |
| Fractyl Health | 101 |
| InflaRx | 74 |
| Entera Bio | 22 |
| ImageneBio | 15 |
| Instil Bio | 14 |
| Actuate Therapeutics | 10 |
EXOZ News
- 2 days ago - Successful Pilot Scale Run with Cayman Chemical Validates eXoZymes' Technology and Scalability - Accesswire
- 7 days ago - eXoZymes' CCO Damien Perriman to Present a NCT Solution at Next Week's MISTA Symposium - Accesswire
- 5 weeks ago - With Refreshed Brand eXoZymes Sharpens Pharmaceutical Focus to Drive Platform Leverage and Long-Term Value Creation - Accesswire
- 7 weeks ago - eXoZymes Advancing Commercial Readiness With Profound Production Metrics on Initial NCT Pilot Run - Accesswire
- 3 months ago - eXoZymes Achieves 100× Scale-up of NCT Production Using Exozymes, Demonstrating Near-perfect Feedstock Conversion - Accesswire
- 4 months ago - eXoZymes Provides Third Quarter 2025 Update at 5PM EST Today - Accesswire
- 4 months ago - eXoZymes Announces Cell-Free Biomanufacturing Pioneer, Tyler Korman, As CSO & Amy Lunzer as Chief of Staff - Accesswire
- 4 months ago - eXoZymes to Host Third Quarter 2025 Update on Thursday November 13, 2025, at 5PM EST - Accesswire